# OnCo record gt-biopharma (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/gt-biopharma/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "gt-biopharma" ;
  schema:name "GT Biopharma"@en ;
  schema:alternateName "GT Biopharma, Inc."@en ;
  schema:description "GT Biopharma is a San Francisco company making proteins that switch on a patient's own natural killer cells, a kind of immune cell, and point them at cancer. Its two lead medicines are in early trials in leukaemia and in solid tumours."@en ;
  schema:url <https://onco.cc/companies/gt-biopharma/>, <https://www.gtbiopharma.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.sec.gov/Archives/edgar/data/109657/000149315226046618/forms-1.htm>, <https://www.gtbiopharma.com/product-pipeline/overview>, <https://www.gtbiopharma.com/> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/nk-cell-engagers/> ;
  onco:targets <https://onco.cc/targets/cd33/>, <https://onco.cc/targets/b7h3/> ;
  onco:drugs <https://onco.cc/drugs/gtb-3650/>, <https://onco.cc/drugs/gtb-5550/> .